Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | pUMVC3-IGFBP2-HER2-IGF1R vaccine |
Trade Name | |
Synonyms | WOKVAC vaccine|WOKVAC |
Drug Descriptions |
pUMVC3-IGFBP2-HER2-IGF1R (WOKVAC) vaccine is a plasmid-based vaccine containing sequences for IGFBP2, ERBB2 (HER2), and IGF1R, which potentially induces immune response against tumors expressing these proteins (Cancer Res February 15 2017 (77) (4 Supplement) OT3-01-03). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C127910 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Paclitaxel + Pertuzumab + pUMVC3-IGFBP2-HER2-IGF1R vaccine + Trastuzumab | Paclitaxel Pertuzumab Trastuzumab pUMVC3-IGFBP2-HER2-IGF1R vaccine | 0 | 1 |
pUMVC3-IGFBP2-HER2-IGF1R vaccine | pUMVC3-IGFBP2-HER2-IGF1R vaccine | 0 | 1 |